ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2000

Changes In The Prevalence Of Gout In The United States General Population Between 1960 and 2010: The National Health and Nutrition Examination Surveys

Eswar Krishnan and Linjun Chen, Medicine, Stanford University, Palo Alto, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Crystal-induced arthritis, Environmental factors, Epidemiologic methods, gout and population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Despite the widely shared impression that the prevalence of gouty arthritis (gout) has increased over time in the US few population data are available.

Methods: We compared the age-gender specific prevalence proportions of self-reported gout from the 1959-1962 and 2009-2010 cycles of National Health and Nutrition Examination Surveys (NHANES). Using mid-period Census data we estimated and compared population-prevalence rates. Age, sex and risk factor adjusted changes were assessed using Poisson regressions.

Results: The estimated number of cases of gout in the US increased from about 1.1 million in 1960 to 8.1 million in 2010.  The proportion of respondents with gout in NHANES increased from 1.1% to 3.7% whereas the unadjusted population-based prevalence of gout increased from 6 per 1000 to 26 per 1000. The increased prevalence was evident among all adults, men and women but was statistically significant and of larger magnitude among those 65 years and older (Figure 1, 2). The proportion of women in the population with gout remained unchanged at 31%. The mean age of the prevalent gout among adults (age>=18) increased from 54 years to 61 years among men and 57 years to 65 years among women. The age-sex adjusted prevalence rate ratio was 2.9 (2.1, 4.1). In Poisson regressions adjusted for age and waist circumference, the prevalence rate ratio decreased to 1.57 (1.18, 2.11). When men and women were studied separately in these regressions, the increase in prevalence was evident among men with rate ratio 1.77 (1.20, 2.60) but not among women with rate ratio 1.16 (0.74, 1.80). When hypertension and diabetes were added to the above model, the prevalence rate ratio was 1.86 (1.28, 2.71) for men and 1.21 (0.81, 2.11) for women.

Conclusion: The population burden of illness from gout has increased substantially in absolute and relative terms in the past 50 years. Both genders and all age groups witnessed increasing rate, the highest rise being evident in men older than 65 years. This increase was explained entirely by increase in abdominal adiposity among women. Among men, however, increased prevalence of abdominal adiposity, hypertension, diabetes, increasing population age only partly explained the increase. At least some of the observed increase could be due to greater disease awareness as the case definition was based on self-report.

Figure 1

Figure 2

 


Disclosure:

E. Krishnan,

Takeda,

2,

Takeda,

2;

L. Chen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/changes-in-the-prevalence-of-gout-in-the-united-states-general-population-between-1960-and-2010-the-national-health-and-nutrition-examination-surveys/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology